Detection of chromosomal aneuploidies in fetal cells isolated from maternal blood using single-chromosome dual-probe FISH analysis

Clinical Genetics

Volumn 82, Issue 2, 2012, Pages 131-139

  Calabrese, G ^a   Baldi, M ^b   Fantasia, D ^a   Teresa Sessa, M ^b   Kalantar, M ^c   Holzhauer, C ^d   Alunni Fabbroni, M ^d   Palka, G ^a   Sitar, G ^e  

^a UNIVERSITY OF CHIETI   (Italy)

^b Laboratorio Genoma   (Italy)

^c Yazd Medical Sciences   (Iran)

^d BECKMAN COULTER INC   (United States)

^e FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

Circulating fetal cells; Down syndrome; FISH; Maternal blood; Prenatal diagnosis

Indexed keywords

BLOOD GROUP I ANTIGEN; MONOCLONAL ANTIBODY;

ANEUPLOIDY; ARTICLE; BLOOD SAMPLING; CELL ISOLATION; CHROMOSOME 18; CHROMOSOME 21; CHROMOSOME ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DUAL PROBE FLUORESCENCE IN SITU HYBRIDIZATION; FEMALE; FETUS CELL; FLUORESCENCE IN SITU HYBRIDIZATION; GENE LOCUS; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; MATERNAL BLOOD; MICROMANIPULATION; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SHORT TANDEM REPEAT; TRISOMY;

ANEUPLOIDY; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 18; DOWN SYNDROME; FEMALE; FETUS; GLYCOSPHINGOLIPIDS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MICROSATELLITE REPEATS; PREGNANCY; PRENATAL DIAGNOSIS; TRISOMY;

EID: 84863785654     PISSN: 00099163     EISSN: 13990004     Source Type: Journal    
DOI: 10.1111/j.1399-0004.2011.01775.x     Document Type: Article

References (28)

1. Alfirevic Z. Prenatal screening for Down's syndrome. A range of options that provide reliable and reproducible results is essential. Br Med J 2009: 338: b140.
2. Buckley F, Buckley SJ. Costs of prenatal genetic screening. Lancet 2008: 372: 18050-18056.
3. Chitty LS, van der Schoot CE, Hahn S, Avent ND. SAFE - the special non-invasive advances in fetal and neonatal evaluation network: aims and achievements. Prenat Diagn 2008: 28: 83-88.
4. Krabchi K, Gros-Louis F, Yan J et al. Quantification of all fetal nucleated cells in maternal blood between the 18th and 22nd weeks of pregnancy using molecular cytogenetic techniques. Clin Genet 2001: 60: 145-150.
5. Klonisch T, Drouin R. Fetal-maternal exchange of multipotent stem/progenitor cells: microchimerism in diagnosis and disease. Trends Mol Medicine 2009: 15: 510-518.
6. Sitar G, Brambati B, Baldi M et al. The use of non-physiological conditions to isolate fetal cells from maternal blood. Exp Cell Res 2005: 302: 153-161.
7. Oosterwijk JC, Mesker WE, Ouwerkerk-van Velzen MC et al. Development of a preparation and staining method for fetal erythroblasts in maternal blood: simultaneous immunocytochemical staining and FISH analysis. Cytometry 1998: 32: 170-177.
8. Krabchi K, Gadji M, Samassekou O Grégoire M-C, Forest J-C, Drouin R. Quantification of fetal nucleated cells in maternal blood of pregnant women with a male trisomy 21 fetus using molecular cytogenetic techniques. Prenat Diagn 2006: 26: 28-34.
9. Lo YM, Tsui NB, Chiu RW et al. Plasma placental RNA allelic ratio permits noninvasive prenatal chromosomal aneuploidy detection. Nat Med 2007: 13: 218-223.
10. Wright CF, Burton H. The use of cell-free fetal nucleic acid in maternal blood for non-invasive prenatal diagnosis. Hum Reprod Update 2009: 15: 139-151.
11. Fan HC, Blumenfeld YJ, Chitkara U, Hudgins L, Quake SR. Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood. Proc Natl Acad Sci USA 2008: 105: 16266-16271.
12. Chiu RW, Akolekar R, Zheng YW et al. Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study. Br Med J 2011: 342: c7401.
13. Hahn S, Lapaire O, Tercanli S, Kolla V, Hösli I. Determination of fetal chromosome aberrations from fetal DNA in maternal blood: has the challenge finally been met? Expert Rev Mol Med 2011: 13: e16.
14. Van der Loos CM. Multiple staining in molecular morphology. In: Hacker GW, Tubbs RR, eds. Molecular morphology in human tissues: techniques and applications. Boca Raton, FL: CRC Press, 2005: 27-63.
15. Twu YC, Chen CP, Hsieh CY et al. I branching formation in erythroid differentiation is regulated by transcription factor C/EBP (alpha). Blood 2007: 110: 4526-4534.
16. Henri A, Testa U, Tonthat H et al. Disappearance of Hb F and i antigen during the first year of life. Am J Hematol 1980: 9: 161-170.
17. Blanchard D, Bernard D, Loirat MJ, Frioux Y, Guimbretière J, Guimbretière L. Caractérisation d'anticorps monoclonaux murins dirigés contre les érythrocytes fœtaux. Rev Fr Transfus Hemobiol 1992: 35: 239-254.
18. Sabattini E, Bisgaard K, Ascani S et al. The EnVision™+ system: a new imunnonhistochemical method for diagnostics and research. Critical comparison with the APAAP, ChemMate, CSA, LABC, and SABC techniques. J Clin Pathol 1998: 51: 506-511.
19. Yan J, Guilbault E, Massé J et al. Optimization of the fluorescence in situ hybridization (FISH) technique for high detection efficiency of very small proportions of target interphase nuclei. Clin Genet 2000: 58: 309-318.
20. Choolani M, O'Donnell H, Campagnoli C et al. Simultaneous fetal cell identification and diagnosis by epsilon-globin chain immunophenotyping and chromosomal fluorescence in situ hybridization. Blood 2001: 98: 554-557.
21. Pahal GS, Jauniaux E, Kinnon C, Thrasher AJ, Rodeck CH. Normal development of human fetal hematopoiesis between eight and seventeenth weeks' gestation. Am J Obstet Gynecol 2000: 183: 1029-1034.
22. Yan Z, Lambert NC, Guthrie KA et al. Male microchimerism in women without sons: quantitative assessment and correlation with pregnancy history. Am J Med 2005: 118: 899-906.
23. Lambert NC, Pang JM, Yan Z et al. Male microchimerism in women with systemic sclerosis and healthy women who have never given birth to a son. Ann Rheum Dis 2005: 64: 845-848.
24. Kølvraa S, Christensen B, Lykke-Hansen L, Philip J. The fetal erythroblast is not the optimal target for non-invasive prenatal diagnosis: preliminary results. J Histochem Cytochem 2005: 53: 331-336.
25. Rastan S, Thorpe SJ, Scudder P, Brown S, Gooi HC, Feizi T. Cell interactions in preimplantation embryos: evidence for involvement of saccharides of the poly-N-acetyllactosamine series. J Embryol Exp Morphol 1985: 87: 115-128.
26. Mergenthaler S, Babochkina T, Kiefer V, Lapaire O, Holzgreve W, Hahn S. FISH analysis of all fetal nucleated cells in maternal whole blood: improved specificity by the use of two Y-chromosome probes. J Histochem Cytochem 2005: 53: 319-322.
27. Kilpatrick MW, Tafas T, Evans MI et al. Automated detection of rare fetal cells in maternal blood: eliminating the false-positive XY signals in XX pregnancies. Am J Obstet Gynecol 2004: 190: 1571-1581.
28. Bianchi DW, Williams JM, Sullivan LM, Hanson FW, Klinger KW, Shuber AP. PCR quantitation of fetal cells in maternal blood in normal and aneuploid pregnancies. Am J Hum Genet 1997: 61: 822-829.